Jeff Galak

CytoAgents is a clinical stage biotechnology company focused on the development of innovative pharmaceutical products for the treatment of life-threatening symptoms associated with Cytokine Release Syndrome (CRS), an overreaction of the immune system causing systemic inflammation. There are many causes of CRS and our mission is to develop a broadly accessible treatment for multiple indications of high unmet need. Using a novel approach by calming the natural immune response to a multi organ disease, CytoAgemts' lead drug candidate, GP1681, is positioned to become a new best practice in medicine.

The Tepper School of Business, located at the heart of Carnegie Mellon in Pittsburgh, PA, is consistently ranked among the top business schools in the world. The school’s legacy is closely tied to our pioneering work in introducing management science to the marketplace and B-school arena. More than 60 years ago, the school’s leadership brought forth their vision of a better way to succeed in business. Management science – the academic alternative to the case study method – has its roots in analytical decision making in complex, dynamic business environments. Its prevalence and popularity has had sweeping effects – today, nearly all leading B-schools include some form of the Carnegie Mellon management science model in their curriculum. A commitment to knowledge discovery via interdisciplinary collaboration is at the heart of our academic philosophy. As a decidedly small school housed within a decidedly small research university, we are a conservatory of innovation. The linkages across campus are numerous and an inherent part of our culture. Partnerships that would be considered unconventional at other schools are what we do best. Tepper students partner with students, professors and researchers in other schools and centers, such as engineering, robotics, biotechnology and life sciences, product design and computer science. SPECIALTIES Accounting, Economics, Financial Economics, Information Systems, Manufacturing and Operating Systems, Marketing, Operations Research as well as Organizational Behavior and Theory DEGREE PROGRAMS Undergraduate Business Undergraduate Economics MBA MSBA - Business Analytics MSPM - Product Management MSCF - Computational Finance MIIPS - Integrated Innovation for Products & Services Doctoral programs in Accounting, Economics, Financial Economics, Information Systems, Manufacturing and Operating Systems, Marketing, Operations Research as well as Organizational Behavior and Theory Executive Education Certification

CytoAgents is a clinical stage biotechnology company focused on the development of innovative pharmaceutical products for the treatment of life-threatening symptoms associated with Cytokine Release Syndrome (CRS), an overreaction of the immune system causing systemic inflammation. There are many causes of CRS and our mission is to develop a broadly accessible treatment for multiple indications of high unmet need. Using a novel approach by calming the natural immune response to a multi organ disease, CytoAgemts' lead drug candidate, GP1681, is positioned to become a new best practice in medicine.

ALung Technologies, Inc. is proud to be a part of LivaNova. ALung developed the Hemolung for treating patients with acute respiratory failure. The Hemolung provides a simple, less invasive form of extracorporeal CO2 removal. By removing carbon dioxide and delivering oxygen directly to the blood, the Hemolung allows the patient’s lungs to rest and heal.

Carnegie Mellon University founder Andrew Carnegie said: "My heart is in the work."​ No statement better captures the passion and drive of our people to make a real difference. At Carnegie Mellon, were not afraid of the work. Our educational environment creates problem solvers, drivers of innovation and pioneers in technology and the arts. Employers in every field say our graduates are ready to hit the ground running the day they graduate. So, join us. Whether youre looking for a career or an education. Or both.